Skip to main content
Equibles
CRL logo

CRL · Charles River Laboratories International, Inc. · Held by Funds

Track CRL — free

Use CRL with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CRL.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$337.97 -2.84 (-0.83%) At close · Nov 13 Play latest call Q2 2026 earnings call transcript
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$16.19B
Shares
47.92M
Volume · Nov 13 838.6K Avg daily vol (3M) 1.05M

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of CRL by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 23.09% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 4.71% 2,256,703
Index ETFs 18.38% 8,807,911
Active ETFs 1.52% 730,277
Active funds 33.20% 15,907,967
Unclassified 1.80% 864,254
All registered funds 59.62% 28,567,112
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding CRL

648 fund positions
Fund Balance Value % of Fund Open
Fidelity Contrafund 1,807,861 $410,004,796 0.23%
VANGUARD TOTAL STOCK MARKET INDEX FUND 1,530,171 $347,027,481 0.02%
Oakmark Select Fund 1,498,000 $339,731,420 4.08%
Allspring Special Mid Cap Value Fund 1,453,264 $329,585,743 2.45%
VANGUARD 500 INDEX FUND 1,247,732 $282,973,140 0.02%
VANGUARD SMALL-CAP INDEX FUND 1,104,850 $250,568,932 0.13%
Invesco S&P 500 Equal Weight ETF 1,001,035 $232,750,648 0.24%
Fidelity 500 Index Fund 625,265 $180,226,384 0.02%
VANGUARD SMALL-CAP VALUE INDEX FUND 699,768 $158,700,385 0.23%
iShares Core S&P 500 ETF 662,569 $150,264,024 0.02%
Invesco Small Cap Value Fund 627,460 $145,890,725 1.31%
State Street(R) SPDR(R) S&P 500(R) ETF Trust 583,762 $132,391,384 0.02%
Ariel Fund 557,758 $126,493,937 4.37%
MFS Mid Cap Growth Fund 434,005 $125,097,601 0.96%
Invesco Value Opportunities Fund 472,534 $109,868,880 1.21%
VANGUARD SELECTED VALUE FUND 399,160 $92,808,692 1.33%
Fidelity Contrafund K6 387,614 $87,906,979 0.23%
VANGUARD WINDSOR FUND 373,293 $86,794,355 0.34%
Columbia Small Cap Growth Fund 283,687 $81,769,941 2.32%
VANGUARD EXPLORER FUND 348,030 $80,920,455 0.37%
State Street(R) Health Care Select Sector SPDR(R) ETF 340,310 $77,178,905 0.19%
iShares Biotechnology ETF 337,267 $76,488,783 0.84%
Victory Sycamore Small Company Opportunity Fund 330,000 $74,840,700 1.59%
T. Rowe Price Health Sciences Fund, Inc. 326,233 $73,986,382 0.62%
Fidelity Value Fund 267,000 $62,080,170 0.59%
U.S. Targeted Value Portfolio 265,368 $61,700,714 0.37%
VANGUARD INSTITUTIONAL INDEX FUND 261,908 $59,398,115 0.02%
VANGUARD CAPITAL OPPORTUNITY FUND 249,500 $56,584,105 0.17%
Oakmark Equity and Income Fund 245,800 $55,744,982 0.95%
VIP Mid Cap Portfolio 227,579 $51,612,641 0.54%
Dimensional U.S. Targeted Value ETF 209,615 $48,737,584 0.34%
Carillon Scout Mid Cap Fund 202,529 $45,931,552 1.08%
ClearBridge Select Fund 196,748 $45,745,877 1.44%
iShares Russell Mid-Cap ETF 201,319 $45,657,136 0.08%
Columbia Disciplined Core Fund 195,143 $45,372,699 0.88%
VANGUARD HEALTH CARE INDEX FUND 150,797 $43,465,727 0.20%
Fidelity Mid Cap Index Fund 185,750 $43,188,733 0.08%
MFS New Discovery Fund 145,395 $41,908,655 1.96%
U.S. SMALL CAP PORTFOLIO 180,131 $41,882,259 0.21%
Fidelity Advisor Small Cap Fund 136,000 $39,200,640 1.65%
Ariel Appreciation Fund 171,201 $38,826,675 4.04%
Schwab U.S. Mid-Cap ETF 133,232 $38,402,792 0.26%
Fidelity Mid-Cap Stock Fund 150,400 $34,969,504 0.39%
T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund 152,400 $34,562,796 0.35%
Dimensional U.S. Small Cap ETF 147,648 $34,329,636 0.22%
Columbia Variable Portfolio - Disciplined Core Fund 146,625 $33,253,084 0.87%
VANGUARD GLOBAL WELLINGTON FUND 109,138 $31,457,937 0.95%
VANGUARD STRATEGIC EQUITY FUND 134,635 $30,533,872 0.25%
JNL/Invesco Small Cap Growth Fund 126,998 $28,801,876 1.42%
AB RELATIVE VALUE FUND, INC. 123,780 $28,072,066 1.48%
Showing 1–50 of 648 positions
Key facts CIK 1100682 CUSIP 159864107 13F (30d) 517 filings 472 filers Visit website Investor relations